You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 11, November 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Platelet Monamine Oxidase in Schizophrenia

An Investigation in Drug-Free Chronic Hospitalized Patients

Frank Owen, PhD; Rachel Bourne, MIBiol; Timothy J. Crow, PhD, MRCPsych; Eve C. Johnstone, MD, MRCPsych; Alan R. Bailey, MRCP; Howard I. Hershon, MD, MRCPsych

Arch Gen Psychiatry. 1976;33(11):1370-1373.


Abstract

• Platelet monoamine oxidase (MAO) activity was investigated in a series of 60 patients with chronic schizophrenic illnesses free from neuroleptic medication, and 70 normal controls. No significant differences in platelet MAO activity or in substrate preference were detected between patients and controls, using tryptamine and tyramine as substrates. Platelet MAO activity did not distinguish patients with positive symptoms from those with negative symptoms alone and did not show any relationship with severity of disease or with a number of clinical features. These findings suggest that low platelet MAO activity cannot be regarded as a genetic marker for schizophrenia. Important determinants of platelet MAO activity yet to be discovered may have contributed to the discrepancies in recent observations of platelet MAO activity in schizophrenia.



Author Affiliations

From the Division of Psychiatry (Drs Owen, Bourne, Crow, and Johnstone), Clinical Research Centre, Harrow, Middlesex, British United Provident Association Medical Centre Research Department (Dr Bailey), King's Cross, London, and Shenley Hospital (Dr Hershon), Radlett, Hertfordshire, England.


Footnotes

Accepted for publication July 19, 1976.

Reprint requests to Division of Psychiatry, Clinical Research Centre, Watford Road, Harrow, Middlesex HAI 3UJ, England (Dr Owen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Family Study of the Association of Increased Ventricular Size With Schizophrenia
DeLisi et al.
Arch Gen Psychiatry 1986;43:148-153.
ABSTRACT  

Skeletal Muscle MAO Activity in the Major Psychoses: Relationship With Platelet and Plasma MAO Activities
Meltzer and Arora
Arch Gen Psychiatry 1980;37:333-339.
ABSTRACT  

Biologic Heterogeneity and Psychiatric Research: Platelet MAO Activity as a Case Study
Buchsbaum and Rieder
Arch Gen Psychiatry 1979;36:1163-1169.
ABSTRACT  

Platelet Monoamine Oxidase in Affective Disorders
Edwards et al.
Arch Gen Psychiatry 1978;35:1443-1446.
ABSTRACT  

Activities of Types A and B MAO and Catechol-O-methyltransferase in Blood Cells and Skin Fibroblasts of Normal and Chronic Schizophrenic Subjects
Groshong et al.
Arch Gen Psychiatry 1978;35:1198-1205.
ABSTRACT  

Decreased Platelet Monoamine Oxidase Activity in Chronic Schizophrenia, Shown With Novel Substrates
Berrettini et al.
Arch Gen Psychiatry 1978;35:600-605.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.